Benzinga’s Top Downgrades (MDC , TEVA, SHPGY, SMI, RAS)

MDC Holdings Inc MDC was downgraded by Macquarie from “outperform” to “neutral.” MDC closed at $34.28 yesterday. MDC’s trailing-twelve-month operating margins are at -7.06%. Oppenheimer downgraded Teva Pharmaceutical Industries TEVA from “outperform” to “perform.” TEVA’s shares closed at $58.67 yesterday. TEVA’s 52-week trading range is $43.35-$ 64.74. JP Morgan downgraded Shire plc SHPGY from “overweight” to “neutral.” SHPGY’s stock closed at $66.22 yesterday. SHPGY’s quarterly earnings growth stands at -23.57% y/y. Semiconductor Manufacturing International SMI has been downgraded by HSBC from “neutral” to “underweight.” SMI closed at $4.65 yesterday. SMI’s quarterly earnings growth stands at -192.93% y/y. RAIT Financial Trust RAS has been downgraded by FBR Capital from “market perform” to “underperform.” RAS’ shares closed at $3.70 yesterday. RAS’ trailing-twelve-month profit margins stand at -95.15% y/y. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsShort IdeasDowngradesMarketsAnalyst RatingsTrading IdeasConsumer DiscretionaryFinancialsHealth CareHomebuildingInformation TechnologyMortgage REIT'sPharmaceuticalsSemiconductorsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!